84-1175-06 Complement C3 (C3 and PZP-like alpha-2-macroglobulin Domain-containing Protein 1, C3, CPAMD1) 100ul C7850-12F

※お見積書はカートで印刷できます

冷凍

特徴

  • Human Complement component 3, C3 (alternative names include acylation-stimulating protein (ASP) C3 is encoded by gene located 19p13.3-p13.2.
  • Because C3, C4, and C5 are strikingly similar suggesting a common evolutionary origin.
  • C3 is an acute phase reactant.
  • Synthesis of C3, a glycoprotein, is induced during acute inflammation.
  • The liver is the main site of synthesis, although small amounts are also produced by activated monocytes and macrophages.
  • A single chain precursor (pro-C3) of approximately 200 kD is found intracellularly; the cDNA shows that it comprises 1,663aa.
  • This is processed by proteolytic cleavage into alpha (~115kD) and beta subunits (~75kD) which in the mature protein are linked by disulfide bonds.
  • Pro-C3 contains a signal peptide of 22aa residues, the beta chain (645 residues) and the alpha chain (992 residues).
  • The 2 chains are joined by 4 arginine residues that are not present in the mature protein.
  • Human C3 has 79% identity to mouse C3 at the nucleotide level and 77% at the aa level.
  • Human C3 concentration in normal human serum is ~1.25mg/ml.
  • Classical and alternative activation pathways of complement converge at C3 step.
  • Activation via either pathway can result in assembly of C3-cleaving enzymes (C3 convertases) on target surfaces.
  • Both C3 convertases cleave the C3 a-chain at peptide bond 77 resulting in production of C3a (Molecular Weight 9083) and C3b fragments (Molecular Weight 80,000).
  • Released C3a peptide is one of the three complement anaphylatoxins.
  • The nascent C3b fragment can form a covalent ester bond with target surface.
  • This covalent attachment of C3b to target acceptors is required for continuation of complement activation.
  • C3 nephritic factor, an IgG antibody against complement components, is demonstrable in some cases of partial lipodystrophy.
  • C3-deficienthomozygotesdeveloped mesangiocapillary glomerulonephritis.
  • Applications:Suitable for use in ELISA.
  • Western Blot, though not tested, may potentially be used as an application.
  • Other applications not tested.
  • Recommended Dilution:ELISA: 1:10,000-50,000 50-100ng control antigen/wellWestern Blot: 1:1000-1:5000 (chemiluminescence technique)Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized powder may be stored at -20°C.
  • Stable for 12 months at -20°C.
  • Reconstitute with sterile ddH2O or PBS.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Reconstituted product is stable for 12 months at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:100ul
  • Host:goat
  • Source Antibody:canine
  • Grade:Affinity Purified
  • Purity:Purified by immunoaffinity chromatography.
  • Form:Supplied as a lyophilized powder from PBS, 0.1% BSA.
  • Specificity:Recognizes canine C3.
  • Isotype:IgG
  • Calc Applications Abbrev:E
  • Calc Crossreactivity:Ca
  • Immunogen:Highly purified canine serum C3 protein.
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1175-06
型番
C7850-12F
入り数
1個
標準価格
236,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る